USPTO serial 90010716
CANTISENSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 28, 2021
- Examiner
- BAKER, JORDAN A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CANTISENSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leo M. Loughlin
Leo M. Loughlin Rothwell, Figg, Ernst & Manbeck, PC901 New York Avenue, N.W.Suite 900 EastWashington, DC 20001Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Recorded health monitoring software; downloadable health monitoring software; information technology, audio-visual, and multimedia devices, namely, portable digital devices in the nature of smartphones, smartwatches, tablets, and wearables, for recording, displaying, receiving health and lifestyle related text, data and files, and featuring sensors for scientific use to be worn by a human or animal to gather biometric data; measuring, detecting, monitoring and controlling devices for the diagnosis of viruses, bacteria, DNA fragments, RNA fragments, proteins and other substances in fluids or another sample collected from a human or an animal body, all for scientific or laboratory use, not for medical use; recorded content, namely, captured digital health data parameters, using biomarkers such as lactate, glucose, and various viruses, bacteria, and protein and other substances in fluids or another sample collected from a human or an animal body; diagnostic apparatus, not for medical purposes, for testing for viruses, bacteria, DNA fragments, RNA fragments, proteins and other substances in fluids or another sample collected from a human or an animal body; instruments for diagnosis for scientific use, namely, for detecting antigens or other specific binding partners of bacterial or virion particles, for determining the presence or absence of specific DNA or RNA segments, oligonucleotides, or proteins and other substances in fluids or another sample collected from a human or an animal body; scientific apparatus and instruments, namely, for detecting antigens or other specific binding partners of bacterial or virion particles, for determining the presence or absence of specific DNA or RNA segments, oligonucleotides, or proteins and other substances in fluids or another sample collected from a human or an animal body; laboratory apparatus and instruments, namely, for detecting antigens or other specific binding partners of bacterial or virion particles, for determining the presence or absence of specific DNA or RNA segments, oligonucleotides, or proteins and other substances in fluids or another sample collected from a human or an animal body | ACTIVE | — |
| 010 | Diagnostic, examination, and monitoring equipment, namely, cantilever-based, immunoassays that enable direct detection of antigens, viruses, bacteria, DNA fragments, RNA fragments, proteins, oligonucleotides and other chemical species, all for medical purposes; medical and veterinary apparatus and instruments, namely, portable devices featuring diagnostic systems, for recording, displaying, receiving health and wellness related text, data and files, and including sensors for medical use to be worn by a human or animal to gather biometric data; diagnostic apparatus for medical purposes, namely, for detection of target molecules in body fluids or other specimen for diagnostics and detection of status; testing apparatus for medical purposes, namely, point-of-care testing devices for detecting antigens, proteins, biomolecules or proteins for determination of infections with viruses or bacteria, laboratory testing devices for detecting antigens, proteins, biomolecules or proteins for determination of infections with viruses or bacteria | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Digital Diagnostics AG
- Other trademarks owned by Digital Diagnostics AG
- Other trademarks owned by Digital Diagnostics AG
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named CANTISENSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 18, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 18, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 18, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 18, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 18, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 18, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 28, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 12, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 12, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 22, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 3, 2021 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Sep 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 30, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 30, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 23, 2021 | ALIE | ASSIGNED TO LIE | — |
| Aug 17, 2021 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Aug 17, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Aug 17, 2021 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 16, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 18, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 18, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 18, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 12, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 5, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 5, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 5, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 5, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 8, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Oct 7, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 6, 2020 | ALIE | ASSIGNED TO LIE | — |
| Aug 28, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 11, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2020 | PCGR | PETITION TO DIRECTOR GRANTED | — |
| Aug 6, 2020 | APET | ASSIGNED TO PETITION STAFF | — |
| Jul 28, 2020 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| Jul 16, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 23, 2020 | NWAP | NEW APPLICATION ENTERED | — |